Sun Pharma Q1 Results : Cons profit falls 20% YoY to Rs 2,278 crore, but revenue rises (...)
Sun Pharma Q1 Results FY26: Sun Pharmaceutical Industries reported a 20% fall in Q1 consolidated net profit, reaching Rs 2,278 crore. Despite this dip, revenue from operations increased by 10% to Rs 13,786 crore. Strong performance in the India market and growth in global innovative medicines (...)
Site référencé: The Economic Times
The Economic Times
Why Indian investors should look at Silver in 2025 : The metal poised for growth
3/08/2025
I am fully desi now, says Motilal Oswal after buying new Mahindra car
3/08/2025
Wild history of jailed Kazakh ex-Premier’s $3 mn mansion makes it a tough sell in a soft market
3/08/2025
Market Trading Guide : NALCO, Emami are buy and sell recommendations on Monday. Up to 8% move seen
3/08/2025
No passports, no study abroad : China limits public employees' travel
3/08/2025
The RSI myth : Does this popular trading indicator actually work ?
3/08/2025
